Clinical Trial Update: Study of Regorafenib in Patients With Advanced Myeloid Malignancies [Phase 1]

View source ↗

Summary

This update reports on a Phase 1 study of regorafenib in patients with advanced myeloid malignancies, including acute myeloid leukemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED